Peripheral blood biomarkers for predicting response to PD-1/PD-L1 inhibitors

Abstract Though programmed cell death protein 1/programmed cell death ligand 1 (PD-1/PD-L1) inhibitors have revolutionized cancer treatment, predicting their therapeutic efficacy largely depends on biomarkers obtained through invasive procedures, which present challenges, particularly for continuous...

Descripció completa

Dades bibliogràfiques

Autors principals:	Shuting Chen, Yingjie Hu, Hanxu Cheng, Shuaiqingying Guo, Yingyan Han, Kezhen Li
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2026-01-01
Col·lecció:	Biomarker Research
Matèries:	Peripheral blood Predictive biomarker PD-1/PD-L1 inhibitors Tumor-derived biomarker Immune cell Cytokines
Accés en línia:	https://doi.org/10.1186/s40364-026-00892-5
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!